Medical Microbiology

Allotransplant 139
Allotype56, 139
Allylamines 357
Alphatoxin 1 6, 231
Alphavirus 440 – 441
Alternariaspp.354, 369
Alveolata 477
Alveolitis,allergic353, 365
Amandibulata 606
Amantadine 404
Ambisensegenome 463
AmebiasisseeAmebosis
Amebosis 499 – 506
clinicalmanifestations
502 – 503
diagnosis 503 – 50 6,625,
639
antibodyassay 506
coproantigendetec-
tion 50 6, 622
coproscopicdiagnosis
503
differentialdiagnosis
50 4–5 06
epidemiology 502
extraintestinal 50 2,503,
506
immunity 503
intestinal 503 – 506
asymptomatic
50 0–5 02
symptomatic 50 0, 503
prevention 506
therapy 506
seealsoEntamoeba
Amikacin 189
Aminocyclitolantibiotics
189
Aminoglycosides 1 89, 195
mechanismofaction 198
resistancemechanisms
202
Aminopenicillins 193
4-Aminoquinolines 533
8-Aminoquinolines 533
Amodiaquine 533
Amoebozoa 477
Amoxicillin 193
AmphotericinB 356
Ampicillin 193
Amplificationculture 408
Amplificationtechniques
21 6–2 17
Anabolicreactions
160 – 161 , 163
Anaerobes
aerotolerant 163
facultative 163

obligate 163

seealsospecificpatho-

gens

Anaerobiccellulitis

246 – 248

clinicalpicture 247

diagnosis 24 8, 651 , 653

pathogenspectrum 246

pathogenesis 247

therapy 248

toxins 246 – 247

Anaphylatoxin 11 3, 139

Anaphylaxis 108 – 1 09, 139

passivecutaneous(PCA)

143

Anaplasmaphagocytophi-

lum 227 , 333

Ancylostoma(ancylosto-

mosis) 54 4, 580 – 582

braziliense 602

caninum580, 602

clinicalmanifestations

582

control 582

diagnosis 58 2, 6 40, 652

duodenale 580

lifecycle 580 – 582

morphology 580

occurrence 580

therapy 582

AncylostomosisseeAncy-

lostoma(ancylostomosis);

Necator(ancylostomosis)

Anemia

aplasticcrises 412

inmalaria 529

Anergy 44

Angiostrongylus(angio-

strongyliosis) 604

cantonensis 604

costaricensis 604

Animaltesting,indiag-

nosticbacteriology 217

Anisakis(anisakiosis) 604

diagnosis 626

Anopheles 616

control 537

seealsoMosquitoes

Anoplura 60 6, 612 – 615

biology 613

medicalsignificance 613

morphology 613

seealsospecificparasites

Anthrax 22 0, 244 – 245

dermal245, 651

diagnosis245, 651

epidemiology 245

inhalational 245

intestinal 245

prophylaxis 245

therapy 245

seealsoBacillusanthra-

cis

Anthropogenicevolution

203

Anthroponoses 26

Antibioticresistance24,

201 – 205

definitions 201

evolutionof 203

geneticvariability 201

mechanisms 202 – 203

multipleresistance 201

problematicbacteria 201

resistanceplasmids 167 ,

16 8, 17 6, 177

selection 201 – 202

tests 204 – 205

seealsospecificbacteria

Antibiotictherapy

187 – 202

chemoprophylaxis

20 6–2 07

combinationtherapy

205 – 206

definitions 187 – 188

efficacy 196 – 197

mechanismsofaction

19 7–1 99

pharmacokinetics 200

sideeffects 200

spectrumofaction 196

seealsoAntibioticresis-

tance;specificinfections

Antibiotic-associatedcoli-

tis 251

Antibodies 4 4, 45 – 46, 10 0,

139

antinuclear(ANA) 139

antiviralprotection 402

autoantibodyresponses

11 0–1 11

combiningsite 140

Fab 52 , 140 – 141

Fcfragment53, 140

monoclonal69, 70

toxic 120

seealsoImmunoglobu-

lins

Antibodyassays 121 – 129

agglutinationreaction

123 – 125

amebosis 506

complementfixation

test(CFT) 125

enzymeimmunoassay

664 AAllotransplant

All rights reserved. Usage subject to terms and conditions of license

Kayser, Medical Microbiology © 2005 Thieme

All rights reserved. Usage subject to terms and conditions of license.